Photodynamic therapy for localised inoperable endobronchial cancer

National Institute for Clinical Excellence
Record ID 32005001256
English
Authors' objectives:

This study aims to assess the current evidence on the safety and efficacy of photodynamic therapy for localised inoperable endobronchial cancer.

Authors' recommendations: 1 Guidance 1.1 Current evidence on the safety and efficacy of photodynamic therapy for localised inoperable endobronchial cancer appears adequate to support the use of this procedure provided that the normal arrangements are in place for audit and clinical governance. 1.2 This procedure is a treatment option for patients with localised endobronchial cancer that is unsuitable for surgical resection. Clinicians should ensure that patients understand the aim of the treatment, especially when its purpose is palliation. Patients should also be informed of the alternative treatment options available. Clinicians should provide them with clear written information and, in addition, use of the Institute's Information for the public is recommended. 1.3 Further research and audit will be useful in clarifying the indications and benefits of this procedure.
Authors' methods: Overview
Details
Project Status: Completed
Year Published: 2005
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England, United Kingdom
MeSH Terms
  • Photochemotherapy
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
Contact
Organisation Name: National Institute for Clinical Excellence
Contact Address: MidCity Place, 71 High Holborn, London WC1V 6NA, UK. Tel: +44 020 7067 5800; Fax: +44 020 7067 5801
Contact Name: nice@nice.nhs.uk
Contact Email: nice@nice.nhs.uk
Copyright: National Institute for Clinical Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.